Notably, diminished FXR expression in the prefrontal cortex has been observed in depressive mouse models, and its modulation significantly influences depression-related behaviors, identifying FXR as a promising therapeutic target (Bao et al., 2021). Here, NR1H4 is linked to depressive symptom measurement.